Thalia Therapeutics Plc (AIM:THAT)
London flag London · Delayed Price · Currency is GBP · Price in GBX
0.6750
0.00 (0.00%)
Aug 14, 2026, 2:29 PM GMT

Thalia Therapeutics Financials Overview

Millions GBP. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
0.010.010.010--
Revenue Growth
2.80%-0.25%272.86%---
Gross Profit
0.010.010.010--
Operating Income
-1.17-1.17-1.22-1.34-1.19-1.84
Net Income
-1.21-1.21-1.06-1.27-1.03-1.54
Earnings Per Share
-0.00-0.00-0.00-0.01-0.01-0.01
EPS Growth
------

Cash & Debt

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
1.081.080.631.031.921.78
Total Debt
------
Net Cash (Debt)
1.081.080.631.031.921.78
Net Cash Growth
-37.52%72.42%-39.05%-46.49%7.60%-49.83%
Net Cash Per Share
0.000.000.000.000.010.01

Cash Flow & CapEx

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-1.16-1.16-0.97-1.21-0.83-1.77
Free Cash Flow
-1.16-1.16-0.97-1.21-0.83-1.77
Free Cash Flow Growth
------

Margins

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
100.00%100.00%100.00%100.00%--
Operating Margin
-16041.04%-16041.04%-16768.76%-68377.83%--
Pretax Margin
-16039.94%-16039.94%-16768.76%-72943.88%--
Profit Margin
-16588.77%-16588.77%-14537.52%-64993.91%--

Valuation

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingAug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
773.39601.52284.621169.81--